Double-masked | 合法藥品大搜索
由JTauber著作·2004·被引用183次—Diquafosoltetrasodiumwaswelltoleratedandwassuperiortoplacebo...Diquafosolhasafavorablerisk/benefitprofileinabroadspectrumofpatientswithdry...PhaseIII;MulticenterStudy;RandomizedControlle
Purpose: To investigate the safety and efficacy of diquafosol tetrasodium, a P2Y2 receptor agonist that stimulates fluid and mucin secretion on the ocular surface, as a novel topical treatment of dry eye disease.
Methods: Subjects with dry eye (n=527) were evaluated in a randomized, double-masked, parallel-group trial comparing 24 weeks of treatment with 2 concentrations of diquafosol (1% and 2%) versus placebo instilled 4 times daily. Corneal staining, conjunctival staining, Schirmer tests, and subjective symptoms of dry eye were evaluated. Use of artificial tears was permitted as necessary.
Results: Subjects treated with 2% diquafosol had significantly lower corneal stainin...
Efficacy and Safety of Topical 3% Diquafosol Ophthalmic ... | 合法藥品大搜索
Diquafosol Completed Phase 3 Trials for Dry Eyes | 合法藥品大搜索
Diquafosol Completed Phase 3 Trials for Dry Eye Syndrome ... | 合法藥品大搜索
Long | 合法藥品大搜索
Efficacy and safety of diquafosol ophthalmic solution in ... | 合法藥品大搜索
A randomised, double | 合法藥品大搜索
Double-masked | 合法藥品大搜索
Inspire Announces Results of Phase III Dry Eye Study | 合法藥品大搜索
【滴舒適點眼液】治療乾性角結膜炎病人之角膜以及結膜上皮損傷
藥品名稱:滴舒適點眼液許可證字號:衛部藥輸字第027852號許可證種類:製 劑適應症:治療乾性角結膜炎病人之角膜以及結膜上皮損...